MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma
出版年份 2013 全文链接
标题
MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 13, Pages 1736-1742
出版商
Springer Nature
发表日期
2013-04-22
DOI
10.1038/onc.2013.126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global Levels of H3K27me3 Track with Differentiation in Vivo and Are Deregulated by MYC in Prostate Cancer
- (2012) Laxmi G. Pellakuru et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
- (2012) D. E. Bauer et al. CLINICAL CANCER RESEARCH
- MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1
- (2012) M T Gómez-Casares et al. ONCOGENE
- Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
- (2012) Michael J. Kluk et al. PLoS One
- Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
- (2011) B. E. Schwartz et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Perturbation of BRD4 Protein Function by BRD4-NUT Protein Abrogates Cellular Differentiation in NUT Midline Carcinoma
- (2011) Junpeng Yan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain
- (2011) William T. Senapedis et al. MOLECULAR BIOLOGY OF THE CELL
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- myc maintains embryonic stem cell pluripotency and self-renewal
- (2010) Natalia V. Varlakhanova et al. DIFFERENTIATION
- Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
- (2010) Nicolas Reynoird et al. EMBO JOURNAL
- Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
- (2010) Sharon Barrans et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody
- (2009) Herbert Haack et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- Acting Locally and Globally: Myc's Ever-Expanding Roles on Chromatin
- (2009) N. V. Varlakhanova et al. CANCER RESEARCH
- Myc-regulated microRNAs attenuate embryonic stem cell differentiation
- (2009) Chin-Hsing Lin et al. EMBO JOURNAL
- NUT Rearrangement in Undifferentiated Carcinomas of the Upper Aerodigestive Tract
- (2008) Edward B. Stelow et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Distinct Thresholds Govern Myc's Biological Output In Vivo
- (2008) Daniel J. Murphy et al. CANCER CELL
- Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest
- (2008) J. C. Acosta et al. MOLECULAR AND CELLULAR BIOLOGY
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4
- (2008) Yi-Jan Lin et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More